Literature DB >> 32167676

Optimization of fermentation conditions for the production of epothilone B.

Rong Long1, Wenjian Yang1, Gangliang Huang1.   

Abstract

Epothilone is a macrolide secondary metabolite which has the same anticancer effect as paclitaxel. Based on a series of single-factor experiments, four factors, temperature, initial pH, rotation speed, and inoculum quantity, which have the greatest influence on yield, were determined. Four factors were designed and orthogonal experiments were carried out to optimize the fermentation conditions. Finally, the best experimental conditions were obtained as follows: 250 ml flapper triangular flask was used. The yield of epothilone B was 39.76 mg/L at 30℃, initial pH = 7.4, rotating speed 200 r/min, inoculation amount 10%, liquid loading amount 50 ml/250 ml, fermentation time 6 days and seed age 60 hr.
© 2020 John Wiley & Sons A/S.

Entities:  

Keywords:  Epothilone B; fermentation conditions; optimization; orthogonal experiment

Mesh:

Substances:

Year:  2020        PMID: 32167676     DOI: 10.1111/cbdd.13682

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

1.  Optimization of fermentation for γ-aminobutyric acid (GABA) production by yeast Kluyveromyces marxianus C21 in okara (soybean residue).

Authors:  Lei Zhang; Yang Yue; Xiujuan Wang; Weichang Dai; Chunhong Piao; Hansong Yu
Journal:  Bioprocess Biosyst Eng       Date:  2022-02-18       Impact factor: 3.210

2.  Improvement of macrolactins production by the genetic adaptation of Bacillus siamensis A72 to saline stress via adaptive laboratory evolution.

Authors:  Yuman Gan; Meng Bai; Xiao Lin; Kai Liu; Bingyao Huang; Xiaodong Jiang; Yonghong Liu; Chenghai Gao
Journal:  Microb Cell Fact       Date:  2022-07-19       Impact factor: 6.352

3.  Study on the Mechanism of Improving HIV/AIDS Immune Function with Jian Aikang Concentrated Pill Based on Network Pharmacology Combined with Experimental Validation.

Authors:  Cancan Shao; Haojie Wang; Feng Sang; Liran Xu
Journal:  Drug Des Devel Ther       Date:  2022-08-18       Impact factor: 4.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.